Evidence Hub

P-1681. Determining Appropriateness of Pneumonia Treatment in Long-Term Care Facilities Pilot Project

C. Adre, Dipen D. Patel, Callyn Wren, Quynh Nhu Dao, Christopher Wilson, Christopher D Evans

Open Forum Infectious Diseases, 2025

10 participants

Abstract

Abstract Background In 2019 IDSA updated the guidelines for community-acquired pneumonia (CAP). To date there are limited AU data in long-term care facilities (LTCFs). The Antimicrobial Appropriateness for Pneumonia in LTCFs (AAPL) Project was developed to determine which antibiotics are most used and their appropriateness in treating pneumonia (PNA) in TN LTCFs using a modified National Antimicrobial Prescribing Survey (NAPS) tool. Methods We recruited five LTCFs to collect retrospective PNA data from January 2023 to February 2023. Pharmacy students collected data for residents meeting a proposed PNA surveillance definition or with a written PNA diagnosis and entered into a REDCap database. Cases were reviewed and scored by two independent reviewers with an appropriateness score based on the NAPS tool (5 = not assessable, 3/4 = inappropriate, and 1/2 = appropriate). Descriptive statistics were used to analyze AAPL data and analyses performed on SAS Version 9.4. Results Thirteen cases were identified and reviewed; two were excluded due to no antibiotics received in the LTCF. Every chart had a written PNA diagnosis with 54.6% CAP and 18.2% HAP. 17.7% of cases had positive chest X-ray, 15.7% had acute decline in at least one daily living activity, and 11.8% had leukocytosis. 84.6% of cases (n=10) had MRSA risk factors). The most common antibiotics used were amoxicillin/clavulanate, ceftriaxone, and levofloxacin. The average duration of therapy was 7 days. 54.5% of antibiotics…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free